Editing Patient Pathways: Lung Cancer (section)

= Available supportive content for cancer patients =

The Croatian translation of several Guides for patients was carried out by the Association of Women with and Treated for Cancer ALL for HER, based on the approval of the European Society for Medical Oncology (ESMO).

'''ESMO Patient Guide Living with Cancer'''

This Patient Guide to Living with Cancer was produced by the European Society for Medical Oncology (ESMO) and the European Cancer Patient Coalition (ECPC) in collaboration with the International Psycho-Oncology Society (IPOS) to help you and others like you during this important time in your life. In this Guide you can find information about support in coping with the new reality of life, life after primary treatment, preventive care and long-term follow-up. It will also help you keep your personal health record, ie plan your health care while living with cancer.

The guide was translated by Dr. sc. Dea Ajduković, and the translation was reviewed by Assoc. Dr. sc. Natalija Dedić Plavetić, MD. specialist int. oncology and on behalf of the patients, psychologist Ljiljana Vukota from the SVE za NJU association.

https://www.esmo.org/content/download/131276/2458900/1/ESMO-Vodic-za-Bolesnike-Zivot-s-Rakom.pdf

'''ESMO Personalized Medicine in Oncology: A Patient Guide'''

This patient guide was launched by the ESMO Personalized Medicine Working Group to help patients, their family members and friends better understand the factors that can influence the personalized approach to cancer prevention, diagnosis and treatment.

This brochure presents current knowledge about the basic principles of personalized medicine, illustrating its application in several types of tumors. Personalized medicine is the future of cancer treatment, and for it to become a reality in the near future and enable better tumor therapy, the role of the patient is key.

In this approach that is expanding and developing, ESMO is committed to educating patients so that they can better understand its main principles and their own contribution to the progress of therapy.

The Croatian translation of the Guide was made possible by the Association of Women with and Treated for Cancer ALL for HER, based on the approval of the European Society for Medical Oncology (ESMO). The text of the Croatian translation was reviewed by: Prof. Ljiljana Šerman, prof. Floriana Bulić-Jakuš and Mrs. Ljiljana Vukota.

https://www.esmo.org/content/download/385655/7486427/1/HR-Personalizirana-Medicina-u-Onkologiji-Vodic-za-Bolesnike.pdf

'''ESMO Immune-Related Adverse Events and their Management: A Guide for Patients'''

This guide is designed to help you and your family, friends and caregivers better understand and manage the side effects associated with immunotherapy. It provides information on the most common toxicities associated with modern immunotherapies (known as “immune checkpoint inhibitors”), how your oncology team can manage these symptoms, and some approaches you can take yourself to reduce their impact. The medical information described in this document is based on the ESMO Clinical Practice Guidelines for the Management of Toxicities from Immunotherapy, which are designed to assist clinicians in the diagnosis, treatment, and follow-up of these events. All ESMO Clinical Practice Guidelines are prepared and reviewed by leading experts using evidence from the latest clinical trials, scientific research, and expert opinion.

The Croatian translation of the guide was reviewed by: representative of the Croatian Society for Internal Oncology: Assoc. Dr. sc. Natalija Dedić Plavetić, representative of the Croatian Thoracic Society: Prof. Dr. sc. Marko Jakopović, representative of the Association of Women with and Treated for Cancer ALL for HER: Ljiljana Vukota.

'''ESMO Cancer treatment during the COVID-19 pandemic: A Guide for patients'''

The guide provides information about the COVID-19 disease and its symptoms, as well as the measures you can take to reduce the risk of infection. Also, the guide provides information about the impact of the COVID-19 pandemic on various aspects of cancer treatment, including possible changes to your treatment plan and medical examinations that may be necessary to protect yourself from infection.

The Croatian translation was reviewed by: Prim. Dr. sc. Paula Podolski, President of the Croatian Senological Society, Assoc. Dr. sc. Borislav Belev, Internist Oncologist, National Representative of the Croatian Society for Internal Oncology at ESMO and Ljiljana Vukota, representative of the SVE za NJU association.

http://www.svezanju.hr/lijecenje-raka-tijekom-pandemije-covid-19-esmo-vodic-za-bolesnike/

'''ESPEN practical guideline: Clinical Nutrition in cancer'''

Malnutrition is a frequent finding in cancer patients and is a consequence of the presence of the tumor and medical and surgical anti-cancer treatments.

Malnutrition negatively impacts quality of life and treatment toxicity, and it is estimated that up to 10-20% of cancer patients die from the consequences of malnutrition, and not from the tumor itself. Therefore, nutrition plays a crucial role in the context of multimodal cancer treatment.

Strong evidence shows that nutritional issues should be taken into consideration from the time of cancer diagnosis, within the diagnostic and therapeutic pathway, and should be managed in parallel with anti-neoplastic treatments. However, worldwide, cancer-related malnutrition is still largely under-recognized, under-diagnosed, and under-treated in clinical practice.

These evidence-based guidelines were developed to translate the current best evidence and expert opinion into recommendations for the multidisciplinary teams responsible for the identification, prevention and treatment of reversible elements of malnutrition in adult cancer patients.

<span id="directory-of-associations-that-offer-supportive-activities-to-cancer-patients"></span>